Age: 52 · Location: Cork, IE · Frame: operator (Founder-builder) · Judge tier: 1 · Judge Focus-44 rank: 2
Former CEO Healthcare 21 (advisory ended 2024)
_Company: None; former HC21/AddLife._
CEO of Healthcare 21 through its EUR170m / 450-staff growth and sale to AddLife 2021 for EUR240m + earn-out.
HC21 EUR170m / 450 staff sold to AddLife 2021 for EUR240m; stepped down as CEO Sep-2022, left boards Apr-2023; advisory ended 2024.
Cork Institute of Technology business degree + masters. Owen Curtin protégé from 2003. Commercial mgr appointed ~age 30. Stepped down 2024 with published family-focus rationale (Lin 44-walk RTÉ + Owen Curtin coverage). Frame approach carefully — family-focus is stated intent, not soft-NO; part-time / founding-partner works, full-time CEO year-one may not.
AVAILABLE_NOW
Outreach window: APPROACH NOW
Owen Curtin (HC21 founder-chair, 72) — offer him a chair seat in same conversation; or PwC Issy Corbett | Owen Curtin protégé since 2003 + HC21 co-shareholder route to Langley (Nordh × Langley shared James Livingston separately)
operator (Founder-builder) · AddLife/Nordic-compounder · L4 bracket STRONG · L1=4 L2=4 L4=4 L5=5 L6=5
Path to seat: sold_and_stayed_founder_now_out
Data gap: Origination-vs-operator credit for HC21 deals; chair vs CEO preference
Data gap: L6 evidence-only rescore: Post-earnout prime; three-step deliberate disengagement 2022→23→24 = considered exit; two years fully out of any seat